Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients
Status:
Recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
This is a biology driven, monocentric study, designed to identify biomarkers of activity of
trabectedin in patients with advanced non-L soft-tissue sarcoma. The aim of this study is to
implement high-throughput profiling technologies to identify predictive biomarkers of
trabectedin efficacy through sequential tumor biopsies and blood sample collection in sarcoma
patients.